Navigation Links
Xceed Ziplex(R) System for Automated Gene-Expression Analysis Wins 2008 R&D 100 Award
Date:8/19/2008

WELLESLEY, Mass., Aug. 19 /PRNewswire/ -- Xceed Molecular, a pioneer in the development of cost-effective, easy-to-use gene-expression analysis systems, announced that R&D Magazine has selected the company's Ziplex System as a recipient of the magazine's prestigious R&D 100 Award. Called the Oscars of Invention by The Chicago Tribune, the 45-year-old R&D 100 Award, is according to R&D, "a mark of excellence known to industry, government, and academia as proof that the product is one of the most innovative ideas of the year." Xceed's Ziplex System - comprising an automated hybridization workstation, Autograph and Xpress Chip(TM) consumable arrays, reagents, and automated analysis/reporting software - is the first integrated system for automated gene-expression analysis.

"We are honored to become a member of this elite group of R&D 100 award winners, whose inventions have contributed so much to society," said Xceed President and CEO, David Deems. "This award is a wonderful testament to the talented team of designers, hardware and software engineers, microarray and biochemistry experts who have worked tirelessly over the years to take a complex, expensive, and time-consuming process - gene-expression analysis - and turn it into a simple, reproducible, and affordable one, where results remain consistent even when samples are run by different people, at different times, or in different sites."

As translational medicine moves from the research laboratory to the clinical laboratory, technology that is affordable, reliable, and easy to operate will be critical. The translational process refines a gene-expression signature from hundreds of genes identified in the research stage to the 10 to 150 genes that comprise the final diagnostic assay. Increasingly, investigators are concerned that experiments conducted at different points in time, at multiple locations, or by multiple users may not be comparable due to inherent variability in analytical technology
'/>"/>

SOURCE Xceed Molecular
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008
2. Xceed Molecular to Launch New Inflammation Xpress Chip(TM)for the Ziplex(R) Automated Gene-Expression Analysis System at Clinical Lab Expo 2008, Booth 2155
3. Xceed Molecular Grants Gen-Probe License to Xceeds Flow-Thru Chip(R) Technology for Multiplex Molecular Diagnostics
4. Xceed Molecular Features Ziplex(R) Automated Gene-Expression System at the Biomarker World Congress, Booth 16
5. Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9.1 Million
6. Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
7. Cephalons 2007 Results Exceed Full Year Sales and Earnings Guidance
8. AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000
9. Center for Molecular Medicine Offers Xceed Ziplex(TM) Services to Research Community
10. CNCA Exceeds Standards in Nutritional Supplement Quality, Protects Public
11. CrossFire Beilstein Database Exceeds Ten Million Compounds
Post Your Comments:
*Name:
*Comment:
*Email: